Table 2.
Univariate and multivariate analyses of risk factors for disease-free survival of prostate cancer.
Variable | Univariate analysis HR (95% CI) | P value | Multivariate analysis HR (95% CI) | P value |
---|---|---|---|---|
NRP1 (high/low) | 1.65 (1.21–2.23) | 0.001 | 1.45 (1.02–2.06) | 0.037 |
Gleason score (>8/<=8) | 2.83 (2.04–3.92) | <0.001 | 1.86 (1.21–2.85) | 0.0046 |
Age (>65/<=65) | 1.12 (0.81–1.54) | 0.51 | NA | NA |
PSA (<=10/>10) | 2.64 (1.39–5.03) | 0.003 | 0.89 (0.43–1.88) | 0.78 |
Stage (T4/T3/T2) | 2.62 (1.74–3.95) | <0.001 | 1.07 (0.59–1.95) | 0.82 |
Lymphatic metastasis (yes/no) | 1.49 (1.06–2.11) | 0.02 | 0.90 (0.61–1.32) | 0.58 |
Surgical margin (positive/negative) | 1.78 (1.33–2.39) | <0.001 | 1.60 (1.12–2.29) | 0.01 |
Biochemical recurrence (yes/no) | 4.56 (3.37–6.15) | <0.001 | 2.96 (2.07–4.24) | <0.001 |